Publicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (20)

2024

  1. Agrypnia Excitata and Supranuclear Vertical Gaze Palsy Linked to Anti-Ma Encephalitis

    Movement Disorders Clinical Practice, Vol. 11, Núm. 5, pp. 571-574

  2. The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models

    Neuro-Oncology, Vol. 26, Núm. 8, pp. 1509-1525

2023

  1. European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)

    Neuro-oncology, Vol. 25, Núm. 1, pp. 37-53

2022

  1. Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas

    JCI Insight, Vol. 7, Núm. 7

  2. Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma

    New England Journal of Medicine, Vol. 386, Núm. 26, pp. 2471-2481

  3. Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort

    Neuro-oncology, Vol. 24, Núm. 10, pp. 1726-1735

2021

  1. Delta-24-RGD, an oncolytic adenovirus, increases survival and promotes proinflammatory immune landscape remodeling in models of AT/RT and CNS-PNET

    Clinical Cancer Research, Vol. 27, Núm. 6, pp. 1807-1820

2020

  1. CLIPPERS syndrome: A case report

    Neurologia

  2. Caspr2 antibody-associated limbic encephalitis: contribution of visual aided analysis of 18F-FDG PET images using normal database comparison

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 39, Núm. 2, pp. 92-95

2018

  1. Management of diffuse glioma

    Presse Medicale

  2. Results of a Policy of Fast Tapering of Steroids After Resection Surgery in Glioblastoma

    World Neurosurgery, Vol. 109, pp. e845-e852

2017

  1. A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients

    Journal of Translational Medicine, Vol. 15, Núm. 1

  2. Emerging clinical issues and multivariate analyses in PET investigations

    Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 61, Núm. 4, pp. 386-404

2015

  1. Descripción de una serie de pacientes con diagnóstico de enfermedad priónica

    Neurologia, Vol. 30, Núm. 3, pp. 144-152

2013

  1. Leptomeningeal carcinomatosis: Prognostic value of clinical, cerebrospinal fluid, and neuroimaging features

    Clinical Neurology and Neurosurgery, Vol. 115, Núm. 1, pp. 19-25

2010

  1. Extrapyramidal syndrome related to lithium-carbamazepine combination therapy at therapeutic serum levels

    Clinical Neuropharmacology, Vol. 33, Núm. 2, pp. 102-103

2009

  1. Facial diplegia and vestibular neuritis secondary to HIV seroconversion syndrome

    Canadian Journal of Neurological Sciences, Vol. 36, Núm. 4, pp. 527-528

  2. Sensory-motor axonal peripheral neuropathy in an advanced breast cancer patient treated with ixabepilone

    Clinical and Translational Oncology, Vol. 11, Núm. 11, pp. 765-766

2008

  1. Seasonal periodicity in SUNCT syndrome

    Cephalalgia, Vol. 28, Núm. 1, pp. 94-96

2006

  1. Sobre el futuro de la neurología joven en España

    Neurologia